China greenlights Elekta linear accelerator
The Chinese regulatory body, the State FDA (SFDA), has granted Elekta permission to sell its linear accelerator, Elekta Compact, in China.
Elekta Compact is a linear accelerator for conventional radiotherapy, configured for countries in need of rapid build-up of additional treatment capacity, the Stockholm, Sweden-based company said. Elekta Compact is based on a combination of technology from Elekta and from the product platform developed by the Chinese company BMEI, which Elekta acquired in 2006.
In May 2008, Elekta received SFDA approval to export Elekta Compact outside China. In June 2008, Elekta completed the process of adding CE marking, allowing Elekta Compact to be marketed in Europe, Latin America and Asia.
Elekta Compact is a linear accelerator for conventional radiotherapy, configured for countries in need of rapid build-up of additional treatment capacity, the Stockholm, Sweden-based company said. Elekta Compact is based on a combination of technology from Elekta and from the product platform developed by the Chinese company BMEI, which Elekta acquired in 2006.
In May 2008, Elekta received SFDA approval to export Elekta Compact outside China. In June 2008, Elekta completed the process of adding CE marking, allowing Elekta Compact to be marketed in Europe, Latin America and Asia.